5.4.20

Podcast 85: An Open Conversation About Insulin With Novo Nordisk | Dr. Todd Hobbs & Ken Inchausti

After a recent announcement from Novo Nordisk I cleared my schedule to record this episode with Dr. Todd Hobbs, Chief Medical Officer for North America and Ken Inchausti, Senior Director of Corporate Communications. In this open discussion they share resources and cost saving programs, details about insulin production, insulin trials and what’s on the horizon for insulin therapies. I learned SO much about a drug I’ve been taking for decades!

Thank you everyone for submitting your questions for this episode. Please feel free to contact me any time if there is someone you would like me to interview.

WATCH ON YOUTUBE:

LINKS:

  • Novocare.com
  • Hotline: 844.NOVO4ME  (M-F, 8:30am-11:00pm, Sat, 11:00am-7:00pm)

Programs:

ANNOUNCEMENTS:

  • Please support the advocacy efforts and future podcasts by making a donation.

Please note: We are not giving medical advice, but only sharing our story and management about life with diabetes. Please seek medical advice from your regular GP or endocrinologist before changing your diabetes regimen.

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.